A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Matthew Maurer, MD
Myeloid Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St Vincent'S Hospital
Sydney, New South Wales, Australia
Recruiting - Integrated Clinical Oncology Network (icon) Pty Ltd
Woolloongabba, Queensland, Australia
Recruiting - the Alfred Hospital
Melbourne, Victoria, Australia
Recruiting - Linear Clinical Research
Murdoch, Western Australia, Australia
Recruiting
- Pusan National Univesity Hospital
Busan, South Korea
Recruiting - Cha University Bundang Medical Center
Gyeonggi-do, South Korea
Recruiting - Seoul National University Hospital
Seoul, South Korea
Recruiting
- National Taiwan University Hospital
Taipei, Taiwan
Recruiting - Taipei Tzu Chi Hospital
Taipei, Taiwan
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jul 2024
- Primary completion
- 31 Dec 2027
- Completion
- 31 May 2028
- Last update posted
- 18 Dec 2025
- Registered enrollment
- 70
- Registry id
- NCT06478693
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.